Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

Published Date: 01 Sep 2023

A recent study found an association between the treatment for chronic myeloid leukemia (CML) with nilotinib (a tyrosine kinase inhibitor).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

SBRT May Beat Brachytherapy in Prostate Cancer

2.

New Gene Therapy Nears EU Nod for Bladder Cancer

3.

EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

4.

Simpler Screening Criteria Could Catch More Lung Cancers

5.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot